| abstract |
The present invention relates to a pharmaceutical composition for the treatment or prevention of cancer by inhibiting a chlorotic pathway (CaCC) and / or anoctamin 1 (ANO1), and more particularly to a pharmaceutical composition comprising an idebanone compound. Such pharmaceutical compositions can provide therapeutic or prophylactic effects of prostate cancer, pancreatic cancer, colon cancer, lung cancer, head and neck cancer, esophageal cancer, gastrointestinal cancer, breast cancer and kidney cancer. |